Filing search / Innovation Pharmaceuticals Inc. / "Chronic"

8-K

EX-99.1

IPIX Innovation Pharmaceuticals Inc.

13 Feb 20

Innovation Pharmaceuticals Phase 1 Trial of Brilacidin for Ulcerative Colitis Meets Primary Endpoints; Positive Topline Results of Oral Brilacidin

4:05pm

alerts is available at: http://www.ipharminc.com/email-alerts/ About Brilacidin for IBD Inflammatory Bowel Disease (IBD) is a hard-to-treat, chronic

POS AM

fjrmukid2sjtb4r2

17 Oct 19

Prospectus update (post-effective amendment)

5:23pm

8-K

EX-99.1

r3zlkz0c64

22 Jul 19

Entry into a Material Definitive Agreement

9:30am

8-K

EX-99.1

8tn9jh3vxuzuvjyjyh

16 May 19

Regulation FD Disclosure

10:15am

8-K

ixqv8ibs 197gvw

17 Dec 18

Departure of Directors or Certain Officers

7:00am

8-K

EX-99.1

89ee3fnyq

29 Jun 18

Innovation Pharmaceuticals Announces $7 million Milestone

2:10pm